Sepsis is a failure that occurs in our body when our immune system reacts in an extreme and exaggerated way to an infection and begins to damage the body's own tissues and organs. When this occurs, it can cause irreversible organ damage and even death.
Currently, in Spain around 17,000 people die each year from sepsis. However, it is estimated that the figure could be even higher, since the diagnosis in critically ill patients can be complicated when inflammation occurs as a result of other underlying pathological processes or when previous use of antibiotics causes cultures to fail. be negative.
Like heart attacks or strokes, sepsis is a medical emergency that requires prompt diagnosis and treatment to prevent further infection and organ failure. The sooner it is detected and treated, the better chance the patient will have of making a full recovery.
Coresys Health is a company that has developed a patient monitor dedicated to the early detection of sepsis and continuous monitoring during recovery. “With our technology, we help the medical and healthcare team in ICUs and Emergency Departments to more reliably detect patients with sepsis in order to start the established protocols earlier, and therefore achieve a faster recovery for the patient”, explains co-founder James Marugg. “We have already initiated contact with specialists in hospitals in Catalonia, the Netherlands, Latin America and the US to carry out clinical trials with sepsis patients”, he comments. “This phase of the project is crucial to validate the correct functioning of the intelligent algorithm that we use for the prediction of sepsis”, he adds.
James Marugg and Erick Weber Jensen are the founding partners of the project. Both have more than 30 years of experience in international business, and are widely connected to doctors and hospitals worldwide.
“The Coresys Health Project began in 2020, with a concept proposal for the topic of sepsis, which we have already begun to present during 2021 at different prestigious medical fairs such as Médica (Germany), Arab Health (Dubai), or the Mobile World Congress”, explains Marugg. “Being founders of another start-up called Quantium Medical on the TecnoCampus, we had no hesitation in establishing Coresys Health there as well,” he adds.
According to data provided by the WHO (World Health Organization), there are 50 million people affected by sepsis worldwide each year, of which 20% of patients end up dying. “However, the death toll can be significantly higher, as it is not always correctly detected, and some deaths are not attributed to sepsis,” says Marugg. “The longer it takes to detect a sepsis patient, the more danger they have of contracting septic shock and dying,” she concludes.
On November 24, the Entrepreneurship Night was held at the TecnoCampus in Mataró. The event, which brought together some 300 people, included as a novelty the first edition of the Antena TrenLab awards.
During the evening, the company Coresys Health won the Award for the best business initiative in the field of technology and innovation. The prize included 12,000 euros and a subsidized stay in the TecnoCampus incubator for a whole year.
"Being a start-up at the beginning of its journey, any financial help is welcome, therefore, the money prize will be directly injected into the company to continue developing and improving the product," explains Marugg. “The award for one year in the incubator paid by TecnoCampus also helps a lot”, she adds.
Marugg emphasizes that they have been collaborating with TecnoCampus for a decade, and that they are extremely happy with the service provided to start-ups at all levels, from the incorporation of the company to the participation in online events with start-ups. hubs in other countries, such as Portugal, the Netherlands or the US.
“This type of service helps us as a start-up to have a broader vision of the technologies that are being developed, and that may be interesting for us, or to value different forms of collaboration”, concludes Marugg.